Yu, Ming-Lung
Tai, Chi‐Ming
Mo, Lein-Ray
Kuo, Hsing-Tao
Huang, Chung-Feng
Tseng, Kuo-Chih
Lo, Ching-Chu
Bair, Ming-Jong
Wang, Szu-Jen
Huang, Jee-Fu
Yeh, Ming-Lun
Chen, Chun-Ting
Tsai, Ming-Chang
Huang, Chien-Wei
Lee, Pei-Lun
Yang, Tzeng-Hue
Huang, Yi-Hsiang
Chong, Lee-Won
Chen, Chien-Lin
Yang, Chi-Chieh
Hung, Chao-Hung
Yang, Sheng‐Shun
Cheng, Pin-Nan
Hsieh, Tsai-Yuan
Hu, Jui-Ting
Wu, Wen-Chih
Cheng, Chien-Yu
Chen, Guei-Ying
Zhou, Guo-Xiong
Tsai, Wei-Lun
Kao, Chien-Neng
Lin, Chih-Lang
Wang, Chia-Chi
Lin, Ta-Ya
Lin, Chih‐Lin
Su, Wei-Wen
Lee, Tzong-Hsi
Chang, Te-Sheng
Liu, Chun-Jen
Dai, Chia-Yen
Chen, Chi-Yi
Kao, Jia-Horng
Lin, Han-Chieh
Chuang, Wan-Long http://orcid.org/0000-0002-2376-421X
Peng, Cheng-Yuan
Funding for this research was provided by:
Ministry of Education (The "Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project)
Taiwan Association for the Study of the Liver
TASL Foundation
Taiwan Liver Research Foundation
Kaohsiung Medical University (MOST 109-2314-B-037-044, KMU-K1110002, MOST 108-2314-B-037-066-MY3, KMU-TC108B06, KMU-TC108B07, KMU-DK109002, 105KMUOR08, KMU-TC109B05)
Kaohsiung Medical University Hospital (KMUH109-9R06, KMUH109-9R05, MOHW109-TDU-B-212-114006, KMUH-IIT-109-2-05, KMHK-DK(C)111004, KMHK-DK(C)111006)
Gilead Hong Kong Ltd
Article History
Received: 7 August 2023
Accepted: 10 October 2023
First Online: 21 January 2024
Declarations
:
: CYP: advisory committee member for AbbVie, Bristol-Myers Squibb (BMS), Gilead, and Roche. MLY: research support (grant) from BMS, Gilead, Merck, and Roche diagnostics; consultant of AbbVie, BMS, Gilead, Roche, and Roche diagnostics; speaker of AbbVie, BMS, Eisai, Gilead, Roche and Roche diagnostics. WLC: advisory board member for AbbVie, BMS, Gilead, PharmaEssentia, Roche, and Vaccitech; speaker for AbbVie, BMS, Gilead, and Roche. Chi‐Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Chung-Feng Huang, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, Chien-Lin Chen, Chi-Chieh Yang, Chao-Hung Hung, Sheng‐Shun Yang, Pin-Nan Cheng, Tsai-Yuan Hsieh, Jui-Ting Hu, Wen-Chih Wu, Chien-Yu Cheng, Guei-Ying Chen, Guo-Xiong Zhou, Wei-Lun Tsai, Chien-Neng Kao, Chih-Lang Lin, Chia-Chi Wang, Ta-Ya Lin, Chih‐Lin Lin, Wei-Wen Su, Tzong-Hsi Lee, Te-Sheng Chang, Chun-Jen Liu, Chia-Yen Dai, Chi-Yi Chen, Jia-Horng Kao, Han-Chieh Lin declare no competing interests.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study.